Question 1

What is driving the growth of the U.S. AI in Precision Medicine Market?

Accepted Answer

Growth is driven by the increasing adoption of AI for personalized treatments, genomic analysis, and clinical decision support, along with a surge in partnerships between technology firms and healthcare providers.

Question 2

Which technology dominates the U.S. AI in Precision Medicine Market?

Accepted Answer

Machine learning (ML) leads the market, as it powers genomic interpretation, drug discovery, and predictive analytics used in oncology and chronic disease management.

Question 3

Why is oncology a major focus area in this market?

Accepted Answer

AI enhances oncology by analyzing tumor genomics, radiogenomic data, and clinical profiles to match patients with targeted therapies, improving treatment precision and outcomes.

Question 4

How is the U.S. FDA supporting AI in precision medicine?

Accepted Answer

The FDA has created clear frameworks for AI-based medical devices, approving tools like Prenosis’s Sepsis ImmunoScore™ and Ibex’s Prostate Detect, ensuring safety while fostering innovation.

Question 5

What challenges are restraining U.S. AI in Precision Medicine Market growth?

Accepted Answer

Major challenges include data privacy concerns, lack of standardized regulations, and bias in AI models, which can affect model accuracy and equitable healthcare delivery.

U.S. AI in Precision Medicine Market - Strategic Insights and Forecasts (2026-2031)

Market Segmentation

By Technology

By Application

By End-user

REPORT DETAILS

Need Assistance?